Gülsüm Emel Pamuk1, Mehmet Şerif Top2, Mehmet Şevki Uyanık3, Hilal Köker3, Mustafa Akker3, Recep Ak3, Ömer Atalay Yürekli4, Yahya Çelik5. 1. Department of Hematology, Trakya University Medical Faculty, Eski Yildiz Cad. Park Apt. No:22 Daire:18, Beşiktaş, Istanbul/Edirne, Turkey. gepamuk@yahoo.com. 2. Department of Psychiatry, Edirne State Hospital, Edirne, Turkey. 3. Department of Internal Medicine, Trakya University Medical Faculty, Edirne, Turkey. 4. Department of Internal Medicine, Sema Hospital, İstanbul, Turkey. 5. Department of Neurology, Trakya University Medical Faculty, Edirne, Turkey.
Abstract
BACKGROUND: In this study, we determined the frequency of migraine headache in iron-deficiency anemia (IDA) patients and whether it was related to anxiety, depression, and somatization. METHODS: We included 127 consecutive IDA patients into the study. All patients were asked validated questions about headache and migraine face-to-face. They were administered validated questionnaires for anxiety-depression The Hospital Anxiety and Depression Scale and somatization. The quality of life (QoL) disturbance associated with headache was marked on a 0-10 VAS. RESULTS: Of all IDA patients, 79.5 % defined headache at any time of their life. In addition, 36.2 % of all IDA patients defined the criteria for migraine. IDA patients with migraine were more frequently smokers and had significantly lower hemoglobin and mean corpuscular volume values (p values < 0.05). The IDA group with migraine had significantly higher mean anxiety score (p = 0.046) and headache-related QoL disturbance score (p = 0.021) than the IDA group without migraine. Migraine patients with aura had lower hemoglobin values (p = 0.02), higher depression scores (p = 0.005), and higher migraine-related QoL disturbance scores than others. CONCLUSIONS: IDA patients have a high frequency of migraine headache. The presence of anxiety and depression have great influence on the presence of migraine in IDA patients.
BACKGROUND: In this study, we determined the frequency of migraine headache in iron-deficiency anemia (IDA) patients and whether it was related to anxiety, depression, and somatization. METHODS: We included 127 consecutive IDA patients into the study. All patients were asked validated questions about headache and migraine face-to-face. They were administered validated questionnaires for anxiety-depression The Hospital Anxiety and Depression Scale and somatization. The quality of life (QoL) disturbance associated with headache was marked on a 0-10 VAS. RESULTS: Of all IDA patients, 79.5 % defined headache at any time of their life. In addition, 36.2 % of all IDA patients defined the criteria for migraine. IDA patients with migraine were more frequently smokers and had significantly lower hemoglobin and mean corpuscular volume values (p values < 0.05). The IDA group with migraine had significantly higher mean anxiety score (p = 0.046) and headache-related QoL disturbance score (p = 0.021) than the IDA group without migraine. Migrainepatients with aura had lower hemoglobin values (p = 0.02), higher depression scores (p = 0.005), and higher migraine-related QoL disturbance scores than others. CONCLUSIONS: IDA patients have a high frequency of migraine headache. The presence of anxiety and depression have great influence on the presence of migraine in IDA patients.
Authors: M Vahdat Shariatpanaahi; Z Vahdat Shariatpanaahi; M Moshtaaghi; S H Shahbaazi; A Abadi Journal: Eur J Clin Nutr Date: 2006-10-25 Impact factor: 4.016
Authors: P Henry; J P Auray; A F Gaudin; J F Dartigues; G Duru; M Lantéri-Minet; C Lucas; A Pradalier; G Chazot; A El Hasnaoui Journal: Neurology Date: 2002-07-23 Impact factor: 9.910
Authors: Stephan von Haehling; Uwe Gremmler; Michael Krumm; Frank Mibach; Norbert Schön; Jens Taggeselle; Johannes B Dahm; Christiane E Angermann Journal: Clin Res Cardiol Date: 2017-02-22 Impact factor: 5.460